Data on prognostic relevance of COX-2 overexpression in all these tumours has been inconsistent and conflicting although most reports indicate an inverse relationship between COX-2 overexpression and survival rates in pancreatic cancer [19,21] and ampullary cancer [32]. Here, PTGS2 is linked to pancreatic neoplasm.